Francis Collins' delaying the release of its COVID-19 vaccine because he wanted more minorities in pharmaceutical trials likely cost lives.
Francis Collins' delaying the release of its COVID-19 vaccine because he wanted more minorities in pharmaceutical trials likely cost lives.